• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FOXP1 和 NDRG1 作为 RAD9 介导的前列腺癌细胞功能的下游效应物发挥不同作用。

FOXP1 and NDRG1 act differentially as downstream effectors of RAD9-mediated prostate cancer cell functions.

机构信息

Center for Radiological Research, Department of Radiation Oncology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.

Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.

出版信息

Cell Signal. 2021 Oct;86:110091. doi: 10.1016/j.cellsig.2021.110091. Epub 2021 Jul 21.

DOI:10.1016/j.cellsig.2021.110091
PMID:34298089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8403642/
Abstract

Metastatic progression is the key feature of prostate cancer primarily responsible for mortality caused by this disease. RAD9 is an oncogene for prostate cancer, and the encoded protein enhances metastasis-related phenotypes. RAD9 is a transcription factor with a limited set of regulated target genes, but the complete list of downstream genes critical for prostate carcinogenesis is unknown. We used microarray gene expression profiling and chromatin immunoprecipitation in parallel to identify genes transcriptionally controlled by RAD9 that contribute to this cancer. We found expression of 44 genes altered in human prostate cancer DU145 cells when RAD9 is knocked down by siRNA, and all of them bind RAD9 at their genomic location. FOXP1 and NDRG1 were down regulated when RAD9 expression was reduced, and we evaluated them further. We demonstrate that reduced RAD9, FOXP1 or NDGR1 expression decreases cell proliferation, rapid migration, anchorage-independent growth, anoikis resistance, and aerobic glycolysis. Ectopic expression of FOXP1 or NDRG1 partially restored aerobic glycolysis to prostate cancer cells with reduced RAD9 abundance, but only FOXP1 significantly complemented the other deficiencies. We thus show, for the first time, that RAD9 regulates FOXP1 and NDRG1 expression, and they function differently as downstream effectors for RAD9-mediated prostate cancer cell activities.

摘要

转移进展是前列腺癌的关键特征,主要负责这种疾病导致的死亡率。RAD9 是前列腺癌的癌基因,其编码的蛋白质增强了与转移相关的表型。RAD9 是一种转录因子,其受调控的靶基因有限,但对于前列腺癌发生至关重要的下游基因的完整列表尚不清楚。我们使用微阵列基因表达谱和染色质免疫沉淀平行鉴定了由 RAD9 转录控制的基因,这些基因有助于这种癌症。我们发现,当 RAD9 被 siRNA 敲低时,人前列腺癌细胞 DU145 中的 44 个基因的表达发生改变,所有这些基因在其基因组位置都与 RAD9 结合。FOXP1 和 NDRG1 的表达在 RAD9 表达降低时下调,我们进一步评估了它们。我们证明,RAD9、FOXP1 或 NDRG1 表达减少会降低细胞增殖、快速迁移、锚定独立生长、抗凋亡和有氧糖酵解。FOXP1 或 NDRG1 的异位表达部分恢复了 RAD9 丰度降低的前列腺癌细胞中的有氧糖酵解,但只有 FOXP1 显著补充了其他缺陷。因此,我们首次表明 RAD9 调节 FOXP1 和 NDRG1 的表达,它们作为 RAD9 介导的前列腺癌细胞活性的下游效应物发挥不同的作用。

相似文献

1
FOXP1 and NDRG1 act differentially as downstream effectors of RAD9-mediated prostate cancer cell functions.FOXP1 和 NDRG1 作为 RAD9 介导的前列腺癌细胞功能的下游效应物发挥不同作用。
Cell Signal. 2021 Oct;86:110091. doi: 10.1016/j.cellsig.2021.110091. Epub 2021 Jul 21.
2
Rad9 protein contributes to prostate tumor progression by promoting cell migration and anoikis resistance.Rad9 蛋白通过促进细胞迁移和抗失巢凋亡促进前列腺肿瘤的进展。
J Biol Chem. 2012 Nov 30;287(49):41324-33. doi: 10.1074/jbc.M112.402784. Epub 2012 Oct 12.
3
The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.前列腺转移抑制基因NDRG1对细胞运动性和侵袭具有差异性调控作用。
Mol Oncol. 2017 Jun;11(6):655-669. doi: 10.1002/1878-0261.12059. Epub 2017 May 2.
4
Regulated expression of the TPβ isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer.FOXP1 和 NKX3.1 对人 T 前列腺素受体 TPβ 同工型的调控表达:对血栓素在前列腺癌中作用的影响。
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3153-3169. doi: 10.1016/j.bbadis.2017.09.005. Epub 2017 Sep 8.
5
Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.Dp44mT 通过转移抑制因子 NDRG1 靶向 AKT、TGF-β 和 ERK 通路,作用于正常前列腺上皮细胞和前列腺癌细胞。
Br J Cancer. 2013 Feb 5;108(2):409-19. doi: 10.1038/bjc.2012.582. Epub 2013 Jan 3.
6
FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.FOXP1是一种雄激素反应性转录因子,它在前列腺癌细胞中负向调节雄激素受体信号传导。
Biochem Biophys Res Commun. 2008 Sep 19;374(2):388-93. doi: 10.1016/j.bbrc.2008.07.056. Epub 2008 Jul 18.
7
Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene.胆固醇和植物固醇对窖蛋白 1 和下游前列腺细胞生长抑制基因的表达有差异调节作用。
Cancer Epidemiol. 2010 Aug;34(4):461-71. doi: 10.1016/j.canep.2010.04.009. Epub 2010 May 12.
8
DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation.DNMT1 和 DNMT3B 通过靶向甲基化控制 RAD9 表达来调节人前列腺癌细胞的致瘤性。
Carcinogenesis. 2021 Feb 25;42(2):220-231. doi: 10.1093/carcin/bgaa088.
9
The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.原癌基因c-Src及其下游信号通路受到转移抑制因子NDRG1的抑制。
Oncotarget. 2015 Apr 20;6(11):8851-74. doi: 10.18632/oncotarget.3316.
10
Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer.FOXP1功能的综合分析揭示了其在前列腺癌中的肿瘤抑制作用。
Mol Endocrinol. 2014 Dec;28(12):2012-24. doi: 10.1210/me.2014-1171.

引用本文的文献

1
From cell cycle control to cancer therapy: exploring the role of CDK1 and CDK2 in tumorigenesis.从细胞周期调控到癌症治疗:探索细胞周期蛋白依赖性激酶1(CDK1)和细胞周期蛋白依赖性激酶2(CDK2)在肿瘤发生中的作用
Med Oncol. 2025 Aug 9;42(9):422. doi: 10.1007/s12032-025-02973-1.
2
Mitochondrial ferritin upregulation by deferiprone reduced neuronal ferroptosis and improved neurological deficits via NDRG1/Yap pathway in a neonatal rat model of germinal matrix hemorrhage.在生发基质出血新生大鼠模型中,去铁酮上调线粒体铁蛋白通过NDRG1/Yap途径减少神经元铁死亡并改善神经功能缺损。
J Cereb Blood Flow Metab. 2025 Mar;45(3):510-527. doi: 10.1177/0271678X241252110. Epub 2024 Sep 24.
3
An integrated analysis of the anticarcinogenic role of forkhead box protein 1 in oesophageal squamous cell carcinoma.叉头框蛋白1在食管鳞状细胞癌中的抗癌作用的综合分析
J Cell Mol Med. 2024 Apr;28(8):e18294. doi: 10.1111/jcmm.18294.
4
The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity.Foxp1的功能通过信号转导和转录激活因子3(STAT3)的活性在膀胱癌的发生发展过程中抑制β-肾上腺素能受体转录。
Open Med (Wars). 2023 Aug 24;18(1):20230647. doi: 10.1515/med-2023-0647. eCollection 2023.
5
DeeP4med: deep learning for P4 medicine to predict normal and cancer transcriptome in multiple human tissues.DeeP4med:用于 P4 医学的深度学习,以预测多种人类组织中的正常和癌症转录组。
BMC Bioinformatics. 2023 Jul 4;24(1):275. doi: 10.1186/s12859-023-05400-2.
6
CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration.CDCA3是皮肤黑色素瘤的一种预后生物标志物,且与免疫浸润相关。
Front Oncol. 2023 Jan 11;12:1055308. doi: 10.3389/fonc.2022.1055308. eCollection 2022.
7
DNA binding by the Rad9A subunit of the Rad9-Rad1-Hus1 complex.Rad9-Rad1-Hus1 复合物的 Rad9A 亚基与 DNA 结合。
PLoS One. 2022 Aug 8;17(8):e0272645. doi: 10.1371/journal.pone.0272645. eCollection 2022.
8
Pyrimidine Biosynthetic Enzyme CAD: Its Function, Regulation, and Diagnostic Potential.嘧啶生物合成酶 CAD:功能、调控及其诊断潜力。
Int J Mol Sci. 2021 Sep 23;22(19):10253. doi: 10.3390/ijms221910253.

本文引用的文献

1
Tumour metabolism and its unique properties in prostate adenocarcinoma.前列腺腺癌中的肿瘤代谢及其独特特性。
Nat Rev Urol. 2020 Apr;17(4):214-231. doi: 10.1038/s41585-020-0288-x. Epub 2020 Feb 28.
2
Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents.靶向 MEK5 可抑制非同源末端连接修复,并使前列腺癌对 DNA 损伤剂敏感。
Oncogene. 2020 Mar;39(12):2467-2477. doi: 10.1038/s41388-020-1163-1. Epub 2020 Jan 24.
3
RAD9A promotes metastatic phenotypes through transcriptional regulation of anterior gradient 2 (AGR2).RAD9A 通过转录调控前梯度 2(AGR2)促进转移表型。
Carcinogenesis. 2019 Mar 12;40(1):164-172. doi: 10.1093/carcin/bgy131.
4
MiR-374b-5p-FOXP1 feedback loop regulates cell migration, epithelial-mesenchymal transition and chemosensitivity in ovarian cancer.miR-374b-5p-FOXP1 反馈环调节卵巢癌细胞迁移、上皮-间充质转化和化疗敏感性。
Biochem Biophys Res Commun. 2018 Oct 28;505(2):554-560. doi: 10.1016/j.bbrc.2018.09.161. Epub 2018 Sep 29.
5
Exosomes in diagnosis and therapy of prostate cancer.外泌体在前列腺癌诊断与治疗中的应用
Oncotarget. 2017 Jun 17;8(57):97693-97700. doi: 10.18632/oncotarget.18532. eCollection 2017 Nov 14.
6
Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis.跨越FOXP1至SHQ1的3p13 - 14基因座缺失与PTEN缺失在前列腺癌发生过程中协同作用。
Nat Commun. 2017 Oct 20;8(1):1081. doi: 10.1038/s41467-017-01198-9.
7
Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells.获得失巢凋亡抗性会促进内皮细胞中 Ras/ERK 和 PI3K/Akt 信号通路及基质重塑的改变。
Apoptosis. 2017 Sep;22(9):1116-1137. doi: 10.1007/s10495-017-1392-0.
8
The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.前列腺转移抑制基因NDRG1对细胞运动性和侵袭具有差异性调控作用。
Mol Oncol. 2017 Jun;11(6):655-669. doi: 10.1002/1878-0261.12059. Epub 2017 May 2.
9
Glucose Metabolism in the Progression of Prostate Cancer.前列腺癌进展过程中的葡萄糖代谢
Front Physiol. 2017 Feb 21;8:97. doi: 10.3389/fphys.2017.00097. eCollection 2017.
10
Epigenetics in cancer stem cells.癌症干细胞中的表观遗传学
Mol Cancer. 2017 Feb 1;16(1):29. doi: 10.1186/s12943-017-0596-9.